The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Case Report

Disseminated Mycobacterium avium intracellulare Infection in an “Immunocompetent” Host

Authors: Kennedy K. Eneh, MD, Mehjabin Zahir, MD, Maximo E. Mora, MD, Frances Schmidt, MD, Danilo Enriquez, MD, Fadi Hammoudeh, MD, Narayan Neupane, MD, Joseph Quist, MD

Abstract

We are reporting the case of a 37-year-old immunocompetent patient who presented with anterior chest wall swelling, jaw swelling and pain, back pain, night sweats, and unintentional weight loss. He underwent mediastinoscopy with lymph node biopsy, which revealed caseating and noncaseating granuloma and special stains positive for acid-fast bacteria. Cultures from two different sites surprisingly grew Mycobacterium avium intercellulare (MAI), and a diagnosis of disseminated MAI was made. He was switched from antituberculous treatment to MAI treatment.


Key Points


* Disseminated NTM has been reported in immunosuppressed patients with renal or cardiac transplantation, chronic corticosteroid use, and leukemia.


* Rare genetic disorders may be associated with disseminated NTM infection.


* Our patient was started on antituberculous medication for suspected pulmonary tuberculosis with good response, but, after undergoing mediastinal lymph node biopsy, he was found to have necrotizing and nonnecrotizing granuloma with special stains positive for acid-fast bacteria.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Diagnosis and treatment of disease caused by nontuberculous Mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Res Crit Care Med 1997;156 (pt 2):S1–S25.
 
2. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, et al. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis2007;45:421–427.
 
3. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005;115:2480–2488.
 
4. Mehta JB, Emery MW, Girish M, et al. Atypical Pott's Disease: localized infection of the thoracic spine due to Mycobacterium avium-intracellulare in a patient without human immunodeficiency virus infection. South Med J 2003;96:685–688.
 
5. Mehta JB, Dutt A, Harvill L, et al. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 1991;99:1134–1138.
 
6. Falkinham JO III. Epidemiology of infection by nontuberculous MycobacteriaClin Microbiol Rev 1996;9:177–215.
 
7. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous Mycobacteria diseases in the United States: Results from a national survey. Am Rev Respir Dis 1987;135:1007–1014.
 
8. Bennett SN, Peterson DE, Johnson DR, et al. Bronchoscopy associated Mycobacterium Xenopipseudoinfections. Am J Respir Crit Care Med 1994;150:245–250.
 
9. Hellinger WC, Smilack JD, Greider JL Jr, et al. Localized soft tissue infections with Mycobacterium avium/Mycobacterium intracellulare complex in immunocompetent patients: granulomatous tenosynovitis of the hand or wrist. Clin Infect Dis 1995;21:65–69.
 
10. Jouanguy E, Döffinger R, Dupuis S, et al. IL-12 and IFN-gamma in host defense against Mycobacteria and Salmonella in mice and men. Curr Opin Immunol 1999;11:346–351.
 
11. Levin M, Newport M. Understanding the genetic basis of susceptibility to Mycobacterial infection. Proc Assoc Am Physicians 1999;111:308–312.
 
12. Holland SM. Immunotherapy of mycobacterial infections. Semin Respir Infect 2001;16:47–59.
 
13. Safdar A, White DA, Stover D, et al. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am J Med 2002;113:756–759.
 
14. Remus N, Reichenbach J, Picard C, et al. Impaired interferon gamma-mediated and susceptibility to mycobacterial infection in childhood. Pediatr Res 2001;50:8–13.
 
15. Ehlers S, Richter E. Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous Mycobacteria in vitro. Clin Exp Immunol 2001;124:229–238.
 
16. Greinert U, Schlaak M, Rüsch-Gerdes S, et al. Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculousMycobacteriaJ Clin Immunol 2000;20:445–452.
 
17. Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. N Engl J Med 1994;330:1348–1355.
 
18. Greinert U, Ernst M, Schlaak M, et al. Interleukin-12 as successful adjuvant in tuberculosis treatment. Eur Respir J 2001;17:1049–1051.
 
19. Katoch VM. Infections due to non-tuberculous Mycobacteria (NTM). Indian J Med Res 2004;120:290–304.